Doctor comes out-tells truth about radical democrats

Pierre Kory is an American critical care physician who gained attention during the COVID-19 pandemic for advocating widespread off-label use of certain drugs as treatments for COVID-19, as president and co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC).[1][2] Kory testified twice to the U.S. Senate regarding COVID-19. During his testimony in December 2020, Kory erroneously claimed that the antiparasitic medication ivermectin was a "wonder drug" with "miraculous effectiveness" against COVID-19.[3]


Early in the COVID-19 pandemic, Kory advocated for using increasing doses of steroids and anticoagulants for hospitalized people with COVID-19, at a time when the general recommendation was merely for supportive care.[6] Kory sees subsequent evidence from the RECOVERY Trial, which showed benefit from lower doses of corticosteroids, as vindicating his approach; medical researcher Kevin J. Tracey has said it is still unknown whether Kory's approach was beneficial or harmful. Kory has used other drugs off-label in his treatment regimens, including famotidine and intravenous vitamin C.[6] Kory gave testimony as a guest of U.S. Senator Ron Johnson at a May 5, 2020, Senate hearing in which he called for use of steroids in COVID-19 patients.[5][7] He resigned from UW Health in May out of frustration of its reluctance to implement such measures.

On December 8, 2020, Kory was a witness at a Senate hearing called by the US Senate Homeland Security Committee Chair Ron Johnson,[14] which was criticized as promoting fringe ideas about COVID-19.[15] Kory described ivermectin as "miraculous" and as a "wonder drug" to be used against COVID-19.


In November 2021 the Journal of Intensive Care Medicine retracted a paper written by Kory, Paul E. Marik, and others. The retraction was triggered when it was found the paper misreported the mortality figures of people treated for COVID-19 with the FLCCC's "MATH+" protocol, falsely making it appear to be an effective treatment.[17][18]

In February 2022, the American Journal of Therapeutics issued an expression of concern against a 2021 systematic review of which Kory had been lead author. The notice said there were suspicions about the integrity of the underlying data on which the paper depended to show that ivermectin was a viable treatment for COVID-19.



en.m.wikipedia.org/wiki/Pierre_Kory